Introduction of oncological case managers in the center of gastrointestinal tumors at the University Hospital Freiburg - An interventional study to analyse the influence on the treatment of oncological patients

Not Applicable

• Conditions: C15; C16; C17; C18; C19; C20; Malignant neoplasm of oesophagus; Malignant neoplasm of stomach; Malignant neoplasm of small intestine; Malignant neoplasm of colon

• Registration Number: DRKS00004591
• Lead Sponsor: Tumorzentrum Freiburg CCCF

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-12-11
• Study Completion: 2013-10-13
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 196

Inclusion Criteria

Oncology patients, presenting with a tumor in the gastroenterological ZGT ambulance.

Exclusion Criteria

Patients who come only for a second opinion in the hospital, patients who are not speaking German.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br>The primary objective of the study is, regarding the impact of the establishment of a case-manager on patient care to measure the<br>a) course of treatment according to the treatment pathways (patient safety)<br>b.) compliance with the time schedule<br>(Patient care)<br>c.) information of the patient<br> (Patient-orientation)<br>d) Satisfaction with care<br> (Patient satisfaction)<br><br>

Secondary Outcome Measures

Name	Time	Method
Implementation targets; contacts with the patient before the first appointment in the ambulance and content of the consultation, the presence of the case-manager during the first consultation with the clinician, number of contacts with the patient in the course and reasons for contact, number of contacts with clinicians and family members in the course and duration of the initial interviews with the doctor .<br>Satisfaction of attending physicians<br>Patient characteristics such as age, sex, diagnosis, staging, and treatment development are also recognized; Patient quality of life; costs of case-managers and their effort,<br>the benefit to the patient, the benefit for the employees and for the hospital versus routine care<br>